Position in SERA
as of Mar 31, 2026
· filed May 8, 2026
Position Value
$213,095
-$103,248 QoQ
Shares Held
104,973
-2.1% QoQ
Ownership
0.266%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2025
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in SERA Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026GSA CAPITAL PARTNERS LLP holds $34,693,166 across 42 Medical Devices names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MDT |
Medtronic plc
|
68,541 | $5,361,962 | |
| 2 | NPCE |
NeuroPace Inc
|
115,535 | $1,835,851 | |
| 3 | QTRX |
Quanterix Corp
|
410,252 | $1,772,288 | |
| 4 | PODD |
Insulet Corp
|
11,310 | $1,721,947 | |
| 5 | INFU |
InfuSystem Holdings, Inc
|
160,439 | $1,548,236 | |
| 6 | VMD |
Viemed Healthcare, Inc.
|
127,591 | $1,454,537 | |
| 7 | BSX |
Boston Scientific Corp
|
32,095 | $1,369,814 | |
| 8 | DXCM |
Dexcom Inc
|
19,820 | $1,334,877 |
All Filings in SERA
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $213,095 | 104,973 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $316,343 | 107,235 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $199,481 | 65,190 | Shares | Sole | 2025-11-07 | |
| 2025-06-30 | $173,219 | 62,534 | Shares | Sole | 2025-07-22 | |
| 2025-03-31 | $101,034 | 27,455 | Shares | Sole | 2025-05-08 | |
| No filing history on record for this holder in this stock. | ||||||